Comparison to Other GLP-1/GIP Therapies Semaglutide: Half-life ~7 days, allowing weekly dosing
There is currently no direct head-to-head trial comparing the two medications
For readers who want more detail about treatment access and support, this guide to GLP-1 support through TrimRx is a helpful resource
Tirzepatide is still one of the strongest compounds in the weight-loss category and remains a benchmark
Recent advancements in SPPS and LPPS methodologies have greatly improved manufacturing efficiency, scalability, and yield
Youll note the boxes that Lilly highlighted in red, the placebo arm, 3mg arm and 3/6/9mg arm all have similar rates of side effects with just slightly higher rates of nausea, fatigue and diarrhea in the 3/6/9mg arm